Search results
Analysts Expect Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) To Breakeven Soon
Simply Wall St. via Yahoo Finance· 1 year agoWe feel now is a pretty good time to analyse Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT)...
Shareholders in Intercept Pharmaceuticals (NASDAQ:ICPT) are in the red if they invested three years...
Simply Wall St. via Yahoo Finance· 2 years agoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shareholders should be happy to see the share price up...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) down to US$672m market cap, but institutional owners...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Intercept Pharmaceuticals implies that they have...
Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT) Low P/S No Reason For Excitement
Simply Wall St. via Yahoo Finance· 1 year agoWith a price-to-sales (or "P/S") ratio of 2.3x Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) may be...
Institutional owners may take dramatic actions as Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT)...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) should be aware of the most powerful...
Why Intercept Pharmaceuticals Stock Is Soaring Today
Motley Fool· 2 years agoShares of Intercept Pharmaceuticals (NASDAQ: ICPT) were soaring 15.7% higher as of 12:02 p.m. ET on Tuesday. It also easily topped the average analysts'...
Intercept Pharmaceuticals (NASDAQ:ICPT) shareholders have endured a 83% loss from investing in the...
Simply Wall St. via Yahoo Finance· 7 months agoIt is a pleasure to report that the Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) is up 67% in the...
Intercept Pharmaceuticals Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St. via Yahoo Finance· 2 years agoIntercept Pharmaceuticals (NASDAQ:ICPT) Third Quarter 2022 ResultsKey Financial Results Revenue:...
Implied Volatility Surging for Intercept Pharmaceuticals (ICPT) Stock Options
Zacks via Yahoo Finance· 2 years agoInvestors in Intercept Pharmaceuticals, Inc. ICPT need to pay close attention to the stock based on...
Intercept Pharmaceutical Stock Shows Market Leadership; Earns 92 RS Rating
Investor's Business Daily· 2 years agoIntercept Pharmaceutical stock had its Relative Strength (RS) Rating upgraded from 89 to 92 Tuesday....